Zollinger Ellison Syndrome is a condition caused by a gastrin-secreting neuroendocrine tumor (a gastrinoma). It leads to very high stomach acid output and recurrent peptic ulcer disease. It is most commonly discussed in gastroenterology, endocrinology, and gastrointestinal (GI) surgery. It is also a classic board-style diagnosis when ulcers are severe, multiple, or treatment-resistant.
Gastrinoma is a type of neuroendocrine tumor that secretes the hormone gastrin. Excess gastrin drives high gastric acid production and can cause peptic ulcer disease and diarrhea. Gastrinoma is most commonly discussed in the setting of Zollinger–Ellison syndrome (ZES). It is used clinically as a diagnostic label and management framework in gastroenterology, endocrinology, and GI surgery.
A Neuroendocrine Tumor is a growth that arises from neuroendocrine cells. Neuroendocrine cells are specialized cells that receive nerve signals and release hormones or hormone-like chemicals. In gastroenterology, Neuroendocrine Tumor most often refers to tumors in the gastrointestinal tract, pancreas, or liver metastases from these sites. The term is commonly used in endoscopy, imaging reports, pathology results, and multidisciplinary cancer care discussions.
Carcinoid Tumor is a term commonly used for a well-differentiated neuroendocrine tumor, most often arising in the gastrointestinal (GI) tract. It describes a tumor made of neuroendocrine cells, which can produce hormones and hormone-like chemicals. In modern practice, many clinicians use “neuroendocrine tumor (NET)” alongside or instead of “Carcinoid Tumor.” The term is commonly used in gastroenterology, pathology reports, and oncology discussions about GI masses and related syndromes.
GIST stands for gastrointestinal stromal tumor. It is a type of mesenchymal (connective tissue) tumor that arises in the digestive tract most often in the stomach or small intestine. GIST is commonly discussed in gastroenterology, GI surgery, oncology, radiology, and pathology. It is usually identified as a mass lesion and evaluated for bleeding, obstruction, or cancer risk.
A Gastrointestinal Stromal Tumor is an uncommon tumor that arises from the connective tissue layer of the gastrointestinal (GI) tract. It most often develops in the stomach or small intestine. In clinical practice, it is discussed in endoscopy, GI imaging, surgical pathology, and oncology care. It is commonly shortened to “GIST” after the full term is introduced.
Hepatorenal Syndrome is a type of kidney dysfunction that occurs in advanced liver disease. It is most often discussed in cirrhosis with portal hypertension and fluid buildup (ascites). It reflects functional (potentially reversible) reduction in kidney filtration rather than primary kidney damage early on. The term is commonly used in hepatology, intensive care, and transplant medicine to describe a specific pattern of acute kidney injury in liver failure.
Budd Chiari Syndrome is a condition caused by blocked blood flow out of the liver. It involves obstruction of the hepatic veins (and sometimes the inferior vena cava). Clinicians use the term to describe a specific pattern of liver congestion and portal hypertension. It is commonly discussed in hepatology, gastroenterology, hematology, and interventional radiology.
Portal Vein Thrombosis is a blood clot (thrombus) in the portal vein or its major branches. The portal vein is the main vessel that carries blood from the intestines and spleen to the liver. Portal Vein Thrombosis is discussed in hepatology, gastroenterology, emergency care, and GI surgery because it can affect liver blood flow and portal pressure. It is commonly identified on abdominal imaging performed for abdominal pain, gastrointestinal (GI) bleeding, infection, or liver disease assessment.
Alpha 1 Antitrypsin Deficiency is an inherited condition that can affect the liver and lungs. It involves low levels or abnormal function of alpha-1 antitrypsin, a protective blood protein made mainly in the liver. In gastroenterology and hepatology, it is commonly discussed when evaluating unexplained liver enzyme abnormalities, cholestasis, fibrosis, or cirrhosis. It is also referenced in multisystem care because the same genetic variants can contribute to lung disease.